Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM

Salah-Eddin Al-Batran, Ralf Dieter Hofheinz, Harald Schmalenberg, Dirk Strumberg, Eray Goekkurt, Stefan Angermeier, Thomas Zander, Jochem Potenberg, Hans Georg Kopp, Daniel Pink, Gabriele Margareta Siegler, Michael Schenk, Ferdinando De Vita, Evaristo Maiello, Timo Gaiser, Disorn Sookthai, Ulli Simone Bankstahl, Claudia Pauligk, Thorsten Oliver Goetze, Nils Homann

Research output: Contribution to journalOriginal Articlepeer-review

21 Citations (Web of Science)
Original languageUndefined/Unknown
JournalJournal of Clinical Oncology
Publication statusPublished - 2020

Cite this